News for 'Sun Pharma'

SRK, Sachin Hug At Swearing In

SRK, Sachin Hug At Swearing In

Rediff.com5 Dec 2024

Mukesh Ambani, accompanied by younger son Anant and younger daughter-in-law Radhika Merchant Ambani, were among the many celebrities who attended Devendra Fadnavis' swearing in at Azad Maidan on Thursday afternoon.

Pharma export body suspends Marion Biotech for no reply on syrup deaths

Pharma export body suspends Marion Biotech for no reply on syrup deaths

Rediff.com30 Dec 2022

The drug maker will lose some incentives if its membership is suspended, sources in Pharmexcil said.

Siemens stock drops rapidly as management flags growth challenges ahead

Siemens stock drops rapidly as management flags growth challenges ahead

Rediff.com31 Dec 2024

Siemens's share price has lost ground in the past few sessions following weak management commentary. The management indicated challenges to the growth outlook due to stagnant private capex and concerns over semiconductor shortages for digital industries. Government infra-spending may regain momentum from January 2025.

How Much Have MFs Invested In HDFC Bank?

How Much Have MFs Invested In HDFC Bank?

Rediff.com16 Aug 2024

With a deployment of Rs 2,720 crore in July, MFs' total investment in HDFC Bank in calendar year 2024 (till now) surged to Rs 48,820 crore.

'Old Or New Tax Regime? I Earn...'

'Old Or New Tax Regime? I Earn...'

Rediff.com13 Feb 2025

Ask rediffGURU and tax expert Mihir Tanna your income tax-related questions.

Adani's clarification on bribery charges lifts markets

Adani's clarification on bribery charges lifts markets

Rediff.com27 Nov 2024

From the 30-share Sensex pack, Adani Ports surged 6 per cent. NTPC, HDFC Bank, Bajaj Finance, Maruti and Axis Bank were among the other gainers. In contrast, Titan, State Bank of India, Asian Paints, Tata Consultancy Services, HCL Tech, Sun Pharma, IndusInd Bank and ICICI Bank were among the laggards.

Spike in crude oil price, FII outflows spook markets

Spike in crude oil price, FII outflows spook markets

Rediff.com13 Jan 2025

From the 30-share blue-chip pack, Zomato cracked nearly 7 per cent. Power Grid, Adani Ports, Tata Steel, NTPC, Tata Motors, Tech Mahindra, Mahindra & Mahindra, Asian Paints, Sun Pharma and UltraTech Cement were the other major laggards. In contrast, Axis Bank, Hindustan Unilever, Tata Consultancy Services and IndusInd Bank were the gainers.

Bengaluru leads as top job hub with 9.3% salary growth: Report

Bengaluru leads as top job hub with 9.3% salary growth: Report

Rediff.com24 Oct 2024

Bengaluru dominated as the country's top city for job opportunities and salary growth as it has registered a 9.3 per cent year-on-year increase, closely followed by Chennai and Delhi, a report said on Thursday. This growth underlines Bengaluru's reputation as a technology and business hub as the average monthly unified salary in the city stood at Rs 29,500, making it the highest-paying city in the country, according to TeamLease Services Jobs and Salaries Primer report for FY24. The report is based on an analysis of unified salaries across temporary and permanent hiring markets.

Trump's tariff threats spooks markets; Sensex down 106 points

Trump's tariff threats spooks markets; Sensex down 106 points

Rediff.com26 Nov 2024

Trump's tariff threats spooks markets; Sensex down 106 points

FDI inflows jump 47.8% to $16.17 bn in Q1

FDI inflows jump 47.8% to $16.17 bn in Q1

Rediff.com3 Sep 2024

Foreign direct investment in India jumped 47.8 per cent to $16.17 billion in April-June this fiscal on healthy inflows in services, computer, telecom and pharma sectors, according to government data. FDI inflows were at $10.94 billion in April-June 2023-24. The data showed that overseas inflows in May rose to $5.85 billion and in June to $5.41 billion from $2.67 billion and $3.16 billion, respectively, in the year-ago period.

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Aurbindo Pharma ranks 2nd among Indian's pharma cos

Rediff.com20 Feb 2018

With sales of over Rs 12,240 crore in nine months of the current financial year, it is ahead of Rs 11,580 crore recorded by Lupin but behind Sun Pharma, which reported Rs 19,350 crore sales.

Large-cap cut-off surpasses Rs 1 trillion as 11 new stocks join the list

Large-cap cut-off surpasses Rs 1 trillion as 11 new stocks join the list

Rediff.com7 Jan 2025

The 100-stock largecap basket of Mutual funds (MFs) has seen a major reshuffle in the latest semi-annual reclassification with seven midcap stocks and four new listings earning the largecap tag. According to a report from Nuvama Alternative & Quantitative Research, the midcap stocks that have been upgraded include CG Power, Rail Vikas Nigam, ICICI Prudential Life Insurance, Polycab India, Indus Towers, Cummins India, and Info Edge.

Rs 24.69 lakh cr of investors' wealth wiped out in 4 days

Rs 24.69 lakh cr of investors' wealth wiped out in 4 days

Rediff.com13 Jan 2025

Investors lost Rs 24.69 lakh crore in market valuation in the last four days of severe drubbing in the equity market. Spike in global crude prices, unabated foreign fund outflows, a strong US jobs data diminishing early rate cut expectations, and the rupee logging its steepest single-day fall in nearly two years dampened investors' sentiment.

Sensex, Nifty rise on buying in bank stocks, positive global cues

Sensex, Nifty rise on buying in bank stocks, positive global cues

Rediff.com29 Oct 2024

From the 30 Sensex pack, State Bank of India jumped 5 per cent, followed by ICICI Bank, Bajaj Finserv, NTPC, Adani Ports, Bajaj Finance and Larsen & Toubro. In contrast, Maruti, Tata Motors, Sun Pharma, Bharti Airtel, IndusInd Bank and Mahindra & Mahindra were among the laggards.

Pushpa 2 stampede row: CM vows to back Telugu cinema

Pushpa 2 stampede row: CM vows to back Telugu cinema

Rediff.com26 Dec 2024

Declaring the Telangana government's support to the Telugu film industry, Chief Minister A Revanth Reddy on Thursday said the former would take steps to make Hyderabad a destination for international film shootings.

Sensex tanks 836 points; Nifty ends at 24,199

Sensex tanks 836 points; Nifty ends at 24,199

Rediff.com7 Nov 2024

From the 30-share Sensex pack, Tata Motors, Tech Mahindra, UltraTech Cement, JSW Steel, Sun Pharma, Asian Paints, IndusInd Bank and ICICI Bank were the major losers. State Bank of India emerged as the only gainer from the pack.

Budget 2025: Consumption-related stocks likely to see further gains

Budget 2025: Consumption-related stocks likely to see further gains

Rediff.com3 Feb 2025

Market reaction to the Union Budget was overall neutral. The income tax "gift" wasn't enough to move the needle. There was some apparent rationalisation of Customs duty structure as well as cuts on import duties of some key components for the telecom and IT industry and duty cuts on vehicle imports. Other proposals related to development of agriculture and rural economy and renewables seem to be generally positive.

FPIs pull out equities worth Rs 976 crore

FPIs pull out equities worth Rs 976 crore

Rediff.com22 Dec 2024

After two weeks of buying, FPIs turned net sellers in Indian equities this week, with a net withdrawal of Rs 976 crore amid a strengthening US dollar and steady rise in US 10-year bond yields, impacting investor sentiment. Foreign Portfolio Investors (FPIs) began the week on a positive note, investing Rs 3,126 crore in equities during the first two trading sessions (December 16-20).

Pharma stocks make a comeback as Covid cases surge

Pharma stocks make a comeback as Covid cases surge

Rediff.com20 Apr 2021

However, experts caution that investors should not expect the big returns they got from the sector between March and September 2020.

Markets slump 1%; Sensex tumbled 821 points

Markets slump 1%; Sensex tumbled 821 points

Rediff.com12 Nov 2024

From the 30-share Sensex pack, NTPC, Asian Paints, HDFC Bank, State Bank of India, Tata Motors, JSW Steel, Maruti and Power Grid were among the major laggards. On the other hand, Sun Pharma, Infosys and ICICI Bank were the gainers.

Sun Pharma recalls over 34k bottles of generic drug in US

Sun Pharma recalls over 34k bottles of generic drug in US

Rediff.com11 Feb 2023

Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing. As per the US Food and Drug Administration's Enforcement Report, the US-based arm of Sun Pharmaceutical Industries is recalling lots of Diltiazem Hydrochloride extended-release capsules which are used to treat angina, high blood pressure and some types of irregular heartbeats.

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

Licences of 14 Patanjali, Divya Pharma products suspended: U'khand to SC

Rediff.com1 May 2024

In an affidavit filed in the top court, the SLA has given details of the steps taken by it against Patanjali and Divya Pharmacy.

Mobikwik leads IPO debut with 90% surge; Vishal, Sai Life gain around 40%

Mobikwik leads IPO debut with 90% surge; Vishal, Sai Life gain around 40%

Rediff.com19 Dec 2024

All the three companies that made their stock market debut on Wednesday delivered huge day-one gains for investors. Shares of digital payment major One Mobikwik Systems surged 90 per cent, while that of fashion retailer Vishal Mega Mart and pharma firm Sai Life Sciences gained around 40 per cent each. These stellar debuts came despite the benchmark indices logging continuous declines since their initial public offerings (IPOs) closed on Friday.

Sensex jumps 603 points; ICICI Bank climbs 3%

Sensex jumps 603 points; ICICI Bank climbs 3%

Rediff.com28 Oct 2024

From the 30 Sensex pack, ICICI Bank climbed 3 per cent after the private sector lender posted a 14.5 per cent growth in standalone profit to Rs 11,746 crore for the second quarter ended September 2024. JSW Steel, Mahindra & Mahindra, Adani Ports, Tata Steel, Sun Pharma, Hindustan Unilever, Tata Motors and State Bank of India were the other big gainers from the pack.

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

'Bharat Serums and Vaccines portfolio can touch Rs 5K cr in 3-4 years'

Rediff.com9 Aug 2024

'Mankind's experience, sharpness, and execution will make it happen. We are not going for short-term gains.'

'Time To Play Tests Not T20s In Markets'

'Time To Play Tests Not T20s In Markets'

Rediff.com4 Feb 2025

'2025 is the year to build a portfolio for the future. Focus this year should be on valuations and visible growth.'

FPI selling spree, IT stocks dampen investor sentiment

FPI selling spree, IT stocks dampen investor sentiment

Rediff.com18 Nov 2024

From the 30-share Sensex pack, Tata Consultancy Services, Infosys, NTPC, HCL Technologies, Axis Bank, Tech Mahindra, Bajaj Finserv, Sun Pharma, IndusInd Bank and Reliance Industries were the major laggards. Tata Steel, Hindustan Unilever, Mahindra & Mahindra, Nestle and State Bank of India were among the gainers.

Markets cheer Trump's triumph; Sensex soars 901 points

Markets cheer Trump's triumph; Sensex soars 901 points

Rediff.com6 Nov 2024

From the 30-share Sensex pack, Tata Consultancy Services and Infosys jumped over 4 per cent each. HCL Technologies, Tech Mahindra, Adani Ports, Larsen & Toubro, Maruti and Reliance Industries were also among big gainers. Titan, IndusInd Bank, Hindustan Unilever, Axis Bank and HDFC Bank were the laggards.

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.

Investors become poorer by Rs 5.29 lakh cr as markets slump

Investors become poorer by Rs 5.29 lakh cr as markets slump

Rediff.com12 Nov 2024

A sharp fall in the equity market made investors poorer by Rs 5.29 lakh crore on Tuesday when the BSE benchmark Sensex tumbled over 800 points. A host of negative triggers -- muted quarterly earnings, continuous foreign fund outflows and weak trends in Asian and European markets -- dragged the benchmark indices lower. The BSE benchmark gauge tumbled 820.97 points or 1.03 per cent to settle at 78,675.18.

Pill Review: Impressive Riteish!

Pill Review: Impressive Riteish!

Rediff.com12 Jul 2024

Riteish Deshmukh makes this medical drama watchable! exclaims Namrata Thakker.

NCB busts online pharma racket to send narcotics to US

NCB busts online pharma racket to send narcotics to US

Rediff.com8 May 2022

The pharmacy, identified by the federal anti-narcotics agency as JR Infinity Pvt Ltd, was located at Domalguda in Telangana's capital city.

Sensex tumbles 553 points on selling in IT stocks

Sensex tumbles 553 points on selling in IT stocks

Rediff.com31 Oct 2024

From the 30-share Sensex pack, Tech Mahindra, HCL Technologies, Tata Consultancy Services, Asian Paints, Infosys and Maruti Suzuki were the biggest laggards.

What You Don't Know About Ambani, Adani Wealth

What You Don't Know About Ambani, Adani Wealth

Rediff.com21 Jan 2025

Ambani and Adani account for a fifth of the net worth of all billionaire promoters in the country and half the combined net worth of the top 10.

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Rediff.com25 Oct 2024

From the 30 Sensex pack, IndusInd Bank plunged over 18.50 per cent after the firm reported a 40 per cent decline in September quarter net profit at Rs 1,331 crore, pulled down by concerns over its asset quality. Mahindra & Mahindra, Larsen & Toubro, NTPC, Adani Ports, Tata Steel, Maruti, Bajaj Finance and Titan were also among the laggards.

Investors return to IPOs with Rs 2.2 trillion bids across three offerings

Investors return to IPOs with Rs 2.2 trillion bids across three offerings

Rediff.com14 Dec 2024

It is not just the secondary market that is witnessing a revival in fortunes. Even the initial public offering (IPO) market have roared back to life, with investors submitting bids worth over Rs 2.2 trillion on the three IPOs that wrapped up on Friday. Fashion retailer Vishal Mega Mart (VMM)'s IPO (fifth largest of the year) garnered 27.3x subscription, with bids exceeding Rs 1.6 trillion.

Sensex tanks 942 pts, Nifty plunges below 24K

Sensex tanks 942 pts, Nifty plunges below 24K

Rediff.com4 Nov 2024

From the 30-share Sensex pack, Sun Pharma, Reliance Industries, Infosys, Tata Motors, Infosys, Titan, Maruti and NTPC were among the major laggards. Mahindra & Mahindra, Tech Mahindra, HCL Technologies and IndusInd Bank were the gainers.

Investors lose Rs 7.15 lakh cr as markets slump

Investors lose Rs 7.15 lakh cr as markets slump

Rediff.com25 Oct 2024

Investors' wealth eroded by a whopping Rs 7.15 lakh crore during the morning trade on Friday as equity markets tumbled, driven by sharp fall in IndusInd Bank shares and unabated foreign fund outflows. The BSE Sensex tanked 708.69 points to 79,356.47 and the NSE Nifty plunged 286.35 points to 24,113.05. Tracking the weak trend in equities, the market capitalisation of BSE-listed firms tumbled Rs 715,739.19 crore to Rs 4,36,63,565.73 crore ($5.19 trillion) during the morning trade.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

Sensex jumps 254 points; pharma, IT stocks drive rally

Sensex jumps 254 points; pharma, IT stocks drive rally

Rediff.com10 Mar 2021

Bajaj Finance was the top gainer in the Sensex pack, rising around 2 per cent, followed by Sun Pharma, Tech Mahindra, Axis Bank, Bajaj Auto and Infosys. NSE Nifty rose 76.40 points to 15,174.80.